- 18 Years of
Investing in Healthcare Innovation
Global investments are Empowering Life Sciences and Medical Technology Companies to Accelerate Growth
$12.24 Trillion
The global healthcare market was valued at $12.24 trillion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.6% from 2023 to 2030.
$200 billion
In 2022, the global pharmaceutical industry invested over $200 billion in research and development (R&D), highlighting the sector’s commitment to innovation and bringing new treatments to market.
Innovation for a Healthier Tomorrow
General Pharma Partners is a healthcare-focused investment firm managing over $150 million in equity capital. We specialize in partnering with emerging companies in life sciences, medical devices, and specialty compounding pharmacies, offering not only capital but strategic support to foster growth.
- Expertise
- OUR VISION
The Future of Healthcare
We have been operating within healthcare for nearly two decades, giving us unparalleled insights into the challenges and opportunities of the industry.
Our portfolio includes companies that have successfully scaled and innovated within the life sciences and medical devices industries.
- How we work
Our Investment Process
Discover
Evaluate
Invest & Grow
- R&D